Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy

膀胱内卡介苗(BCG)免疫疗法引起的肺炎

阅读:1

Abstract

Intra vesical Bacillus Calmette-Guérin (BCG) instillation therapy is a well-established treatment for superficial bladder cancer, though it can occasionally lead to rare systemic complications. We report the case of a man in his early 80s who developed acute onset dyspnoea after receiving BCG therapy. Clinical evaluation supported by pathology and multi-modal imaging including X-rays, CTs and PET scans led to a diagnosis of BCG-induced pneumonitis, a rare but serious complication. The exact underlying mechanism is still not fully understood and thus no standardized treatment protocol exists. Success has been reported in the literature with the use of anti-tuberculous drugs in combination with steroids. Our patient was successfully treated with anti-tuberculous medication only, for 4 months. This case highlights the importance of maintaining awareness for systemic BCG findings in patients undergoing intra vesical BCG instillations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。